Your browser doesn't support javascript.
loading
Reply to Reske et al.: PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions.
Afshar-Oromieh, A; Malcher, A; Eder, M; Eisenhut, M; Linhart, H G; Hadaschik, B A; Holland-Letz, T; Giesel, F L; Kratochwil, C; Haufe, S; Haberkorn, U; Zechmann, C M.
Eur J Nucl Med Mol Imaging ; 40(6): 971-2, 2013 Jun.
Article in En | MEDLINE | ID: mdl-23558688
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligopeptides / Prostatic Neoplasms / Carcinoma / Tomography, X-Ray Computed / Edetic Acid / Radiopharmaceuticals / Glutamate Carboxypeptidase II / Positron-Emission Tomography / Multimodal Imaging / Gallium Radioisotopes Type of study: Diagnostic_studies Limits: Humans / Male Language: En Journal: Eur J Nucl Med Mol Imaging Journal subject: MEDICINA NUCLEAR Year: 2013 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligopeptides / Prostatic Neoplasms / Carcinoma / Tomography, X-Ray Computed / Edetic Acid / Radiopharmaceuticals / Glutamate Carboxypeptidase II / Positron-Emission Tomography / Multimodal Imaging / Gallium Radioisotopes Type of study: Diagnostic_studies Limits: Humans / Male Language: En Journal: Eur J Nucl Med Mol Imaging Journal subject: MEDICINA NUCLEAR Year: 2013 Document type: Article